Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05181891 · ClinicalTrials.gov registry record · Phase 2
Pharmaceutically-Enhanced Reinforcement for Reduced Alcohol and Smoking
A Phase 2 study of Alcohol Use Disorder (AUD) and Nicotine Use Disorder, sponsored by Washington State University.
- Recruiting
- Registry status
- Phase 2
- Development phase
- 205
- Enrollment target
- 1
- Study location
NCT05181891 is a Phase 2 study of Alcohol Use Disorder (AUD) and Nicotine Use Disorder that is actively recruiting participants, run by Washington State University. The registered enrollment target is 205 participants, below the 1,817-participant average among 30 other Alcohol Use Disorder (AUD) trials with a reported enrollment target (89% lower). The trial reports 1 study location across 1 state.
The verdict
NCT05181891, a Phase 2 study of Alcohol Use Disorder (AUD) and Nicotine Use Disorder, is actively recruiting participants, sponsored by Washington State University.
- RECRUITING
- Registry status
- Phase 2
- Development phase
- 205 participants
- Enrollment target
- 1
- Study location
Study Summary
Using a randomized controlled trial (RCT), the goal of this study is to evaluate the ability of evidence based behavioral treatment (contingency management: CM) to significantly decrease alcohol use and cigarette smoking among treatment-seeking smokers with an alcohol use disorder (AUD) who have initiated pharmacotherapy (varenicline; VC) for smoking cessation.
Conditions Studied
Interventions
- BEHAVIORAL Contingency Management
- BEHAVIORAL Non-contingent control
Study Locations (1)
Washington
- Washington State University - Spokane
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 205 participants |
| Start Date | 2022-07-11 |
| Est. Completion | 2026-05-01 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05181891
The ClinicalTrials.gov registry entry for NCT05181891 describes a study currently listed as recruiting, categorized as Phase 2. The registered enrollment target is 205 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,817-participant average among 30 other Alcohol Use Disorder (AUD) trials with a reported enrollment target (89% lower). The listed sponsor is Washington State University, which has 64 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Alcohol Use Disorder (AUD) appearing as the primary indexed condition, and to 2 interventions - of which Contingency Management is the first listed.
NCT05181891 reports 1 study location spanning 1 distinct geographic area - top geographies include Washington.
Frequently Asked Questions
What is clinical trial NCT05181891 about?
NCT05181891 is a clinical study titled "Pharmaceutically-Enhanced Reinforcement for Reduced Alcohol and Smoking". Using a randomized controlled trial (RCT), the goal of this study is to evaluate the ability of evidence based behavioral treatment (contingency management: CM) to significantly decrease alcohol use and cigarette smoking among treatment-seeking smokers with an alcohol use disorder (AUD) who have ini...
What is the current status of trial NCT05181891?
This trial is currently recruiting. It is a Phase 2 study. The enrollment target is 205 participants. The study started on 2022-07-11. Estimated completion is 2026-05-01.
What conditions does trial NCT05181891 study?
This clinical trial studies the following conditions: Alcohol Use Disorder (AUD), Nicotine Use Disorder.
What interventions are being tested in trial NCT05181891?
The interventions under investigation include: Contingency Management (BEHAVIORAL), Non-contingent control (BEHAVIORAL).
Who is sponsoring clinical trial NCT05181891?
This trial is sponsored by Washington State University, which has 64 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05181891 being conducted?
This trial has 1 study location across Washington. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Alcohol Use Disorder (AUD)
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Alpha-1 Blockade for Alcohol Use Disorder (AUD)
RECRUITING · Phase 2
-
Off-Label Medications for Alcohol Use Disorder Among Patients With HIV: Pilot Study 3 Semaglutide
RECRUITING · Phase 2
-
Psilocybin With Psychological Support (Psi-PS) for Military Veterans and First Responders With Co-occurring PTSD & Alcohol Use Disorder (AUD)
RECRUITING · Phase 2
-
Study of Tirzepatide for Recovery and Alcohol Use Management
RECRUITING · Phase 2
-
Suvorexant for Treatment of AUD and PTSD
RECRUITING · Phase 2
-
Probenecid Administration for Alcohol Craving and Consumption
RECRUITING · Phase 2
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.